CClinicalTrials.gg
RecruitingNCT07487090Updated Mar 23, 2026

Fasted vs. Fed State Exercise

A Phase 2 interventional study of 16 week exercise intervention in Obesity, Exercise and Weight Loss, sponsored by Arkansas Colleges of Health Education. Recruiting at 1 site in United States. Open to participants aged 18 Years to 59 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-23.

Sponsored by Arkansas Colleges of Health Education · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Started Jan 2026; still recruiting 9 months later.
Phase
Phase 2
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 59 Years
Sex
All
01

Study summary

Although many medications exist for both heart disease and obesity, cost, lack of access for all people, side effects and the desire for a more natural solution have left many people seeking lifestyle treatments such as exercise. Scientists know that exercise is highly beneficial for heart health. When exercise also produces weight loss, these benefits are much improved. Although using exercise to treat or prevent heart disease / obesity is recommended, not all people respond well. Some see significant weight loss and health improvements while others see little changes. For these reasons, new strategies surrounding the use and design of an exercise program are needed. One such strategy could be performing aerobic exercise before breakfast (fasted exercise). When exercising fasted, food/energy stores are low, and one relies on stored body fat for energy. This may help heart health and weight loss. This has never been tested in a program long enough to see such changes. This study will, for the first time, assess the effects of a 16-week aerobic exercise program performed fasted compared to after eating. Outcomes will include blood fats, blood pressure, fat-burning abilities and weight loss.

Starting an exercise program can also make people to eat more. This limits the success of exercise. The study will also evaluate ways fasted exercise could change eating, as it possible that fasted exercise could also cause people to eat more, which would limit weight loss and health improvements.

Read the detailed description

This study will be the first to evaluate a long-term (16-week) aerobic exercise intervention performed in the fasted state (compared to fed state) at a guidelines-based dose. Primary outcomes for Aim 1 will include changes in fat \& fat-free mass (DXA), energy compensation, blood pressure \& lipids, aerobic fitness, and substrate oxidation (respiratory quotient, RQ) at rest and during activity.

It is also important to understand sources of response variability to an exercise program. Individuals tend to compensate for the energy they expend during exercise, primarily by increasing energy intake (EI). Such compensatory eating behaviors likely stem from a series of evolutionarily conserved responses, ensuring energy is available for vital organ function and reproduction when faced with an energy deficit. This proposal will be the first to evaluate how fasted exercise training influences (Aim 2 outcomes): physiological hunger (hormonal responses to a standardized meal) and behavioral constructs shown to influence EI and weight status (food reinforcement and attentional bias towards food cues). The overall hypothesis is that fasted state exercise will result in greater energy compensation, attenuating weight loss compared to an identical dose of exercise performed in the post-prandial state. This study will further hypothesize an attenuated weight loss with fasted exercise training will negate beneficial cardiovascular adaptations stemming from improvements in oxidative metabolism commonly associated with fasted exercise. Adults (aged 18-59 years, BMI: 25-45 kg/m2) will be randomized to a 16-week supervised aerobic exercise intervention (progressing to a guidelines-based dose of 1600 kcal/wk). Exercise sessions will be performed between 0500h and 1100h, 4 days per week in either the fasted state (FAST, 8-12 hour fast) or post-prandially (FED, within 3 hours of eating at least 300 kcal).

02

Conditions studied

  • Obesity
  • Exercise
  • Weight Loss

Keywords

  • Exercise
  • weight loss
  • obesity
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's planned enrollment of 40 is below the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Arkansas Colleges of Health Education is the lead sponsor of 8 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 59 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Aged 18-59
  • BMI 25-45
  • Healthy enough to exercise

Exclusion criteria

Exclusion Criteria:

  • Taking medications or supplements that are known to influence energy expenditure,
  • Currently exercising more than once per week
  • Currently dieting for weight loss
  • Currently taking weight loss drugs
  • Have had a previous weight loss surgery
  • Currently diagnosed with Diabetes
  • Currently diagnosed with heart disease (Heart failure, uncontrolled hypertension, uncontrolled hypercholesterolemia, Coronary heart disease)
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Fasted group

    Complete all exercise sessions of intervention before breakfast- fasted at least 8 hours

    Behavioral: 16 week exercise intervention

  • Experimental
    Fed exercise group

    Complete all exercise sessions of intervention after breakfast- within 3 hours of eating at least 300 kcal

    Behavioral: 16 week exercise intervention

Interventions

  • Behavioral16 week exercise intervention

    Both groups will receive a 16-week supervised aerobic exercise program progressing to 1,600 kcal of EE per wk (4 sessions/week) at moderate intensity (40-50% heart rate reserve, HRR).

06

What researchers measure

Primary outcomes

  1. body composition

    kg of fat free and fat mass via DXA

    Time frame: Baseline (week 0) and post-intervention (week 25)

Secondary outcomes

  1. Total and acylated ghrelin

    Total and acylated ghrelin (pg/mL in plasma) will be assessed in the fasted state and response to a test meal via blood sampling at 0 minutes (pre meal), 15, 30, 45, 60, 90, and 120 minutes post-meal.

    Time frame: Baseline (week 0) and post-intervention (week 25)

  2. GLP-1

    Glucagon-like peptide 1 (GLP-1, Pmol/L in plasma) will be assessed in the fasted state and response to a test meal via blood sampling at 0 minutes (pre meal), 15, 30, 45, 60, 90, and 120 minutes post-meal.

    Time frame: Baseline (week 0) and post-intervention (week 25)

  3. PYY

    Peptide YY (PYY, pmol/L plasma) will be assessed in the fasted state and response to a test meal via blood sampling at 0 minutes (pre meal), 15, 30, 45, 60, 90, and 120 minutes post-meal.

    Time frame: Baseline (week 0) and post-intervention (week 25)

  4. Leptin

    Leptin (ng/mL in plasma) will be assessed in the fasted state and response to a test meal via blood sampling at 0 minutes (pre meal), 15, 30, 45, 60, 90, and 120 minutes post-meal.

    Time frame: Baseline (week 0) and post-intervention (week 25)

  5. Food reinforcement

    amount of work one is willing to do for a snack food

    Time frame: Baseline (week 0) and post-intervention (week 25)

  6. Attentional bias for food cues

    percentage of time fixated on food cues during a dot-probe task, assessed by eye tracking

    Time frame: Baseline (week 0) and post-intervention (week 25)

  7. Skeletal muscle efficiency

    kcal expended per kg per watt during a graded cycle ergometer test

    Time frame: Baseline (week 0) and post-intervention (week 25)

  8. walking ecconomy

    Gross energetic cost of movement (J/kg/m) will be assessed during a graded walking test with indirect calorimetry.

    Time frame: Baseline (week 0) and post-intervention (week 25)

  9. resting metabolic rate

    Resting metabolic rate assessed via indirect calorimetry

    Time frame: Baseline (week 0) and post-intervention (week 25)

  10. muscle strength

    Peak torque and work per repetition (Foot-Pounds) will be assessed during an isokinetic and isometric task

    Time frame: Baseline (week 0) and post-intervention (week 25)

  11. muscle power

    Average power (watts) will be assessed during an isokinetic and isometric task

    Time frame: Baseline (week 0) and post-intervention (week 25)

  12. skeletal muscle mass

    The D3Cr dilution technique will be used to determine kg of skeletal muscle mass

    Time frame: Baseline (week 0) and post-intervention (week 25)

07

Study locations

1 of 1 sites recruiting
  • Arkansas Colleges of Health Education Research Institure Health and Wellness Center
    Fort Smith, Arkansas 72916, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07487090
Lead sponsor
Arkansas Colleges of Health Education
Responsible party
Kyle Flack (Director of the Center for Translational Research, Associate Professor of Pathology, Pharmacology & Physiology, Arkansas Colleges of Health Education) — Principal investigator
First posted
Mar 23, 2026
Start date
Jan 5, 2026
Primary completion
Jul 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Mar 23, 2026

Study contacts

Kyle D Flack, PhD
Contact
kyle.flack@achehealth.edu
(479) 434-4019
Blake Metcalf, DCN
Contact
blake.metcalf@achehealth.edu
479-434-4003

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion